Novo CEO: Victoza worth study as obesity drug - FiercePharma
Links shared publicly online about this topic.
- 924total visits
Novo CEO: Victoza worth study as obesity drug - FiercePharma
Novo Nordisk's new diabetes remedy Victoza has posted impressive uptake since its U.S. launch in February. But the company already has its eyes on broader use of the drug. Novo is eyeing the... Read more...
View full resource at fiercepharma.com
Tags: Diabetes, Diabetes Type 2 Medication, Obesity, Obesity Medication, Drug, Victoza, Novo Nordisk
Most Recently Shared on August 24, 2010 at 2:39 pm By:
Novo CEO: Victoza worth study as obesity drug. http://bit.ly/djhPf6
Advertisement
